1 World Health Organzation.Cervical cancer[EB/OL].(2022-02-22)[2023-12-12].https://www.who.int/news-room/fact-sheets/detail/cervical-cancer. 2 Ault KA.Epidemiology and natural history of human papillomavirus infections in the female genital tract[J].Infect Dis Obstet Gynecol,2006,2006:40470. 3 World Health Organization.World Health Assembly adopts global strategy to accelerate cervical cancer elimination[EB/OL].(2020-08-19)[2023-12-1].https://www.who.int/news/item/19-08-2020-world-health-assembly-adopts-global-strategy-to-accelerate-cervical-cancer-elimination. 4 妇幼健康司.卫生部、全国妇联关于印发《农村妇女“两癌”检查项目管理方案》的通知[EB/OL].(2009-06-30)[2024-01-17].https://www.nhc.gov.cn/wjw/gfxwj/200906/e1bed16a6c9b4a07b00389ab9ab202a8.shtml. 5 Zhang M,Zhong Y,Wang L,et al.Cervical cancer screening coverage - China,2018-2019[J].China CDC Wkly,2022,4(48):1077-1082. 6 World Health Organzation.A cervical cancer-free future:First-ever global commitment to eliminate a cancer [EB/OL].(2020-11-17)[2024-01-17].https://www.who.int/news/item/17-11-2020-a-cervical-cancer-free-future-first-ever-global-commitment-to-eliminate-a-cancer. 7 Yang H,Li SP,Chen Q,et al.Barriers to cervical cancer screening among rural women in eastern China:a qualitative study[J].BMJ Open,2019,9(3):e026413. 8 Nyabigambo A,Mayega RW,Mendoza H,et al.The preference of women living with HIV for the HPV self-sampling of urine at a rural HIV clinic in Uganda[J].S Afr J Infect Dis,2022,37(1):414. 9 Xu H,Yu Y,George W,et al.Comparison of the performance of paired urine and cervical samples for cervical cancer screening in screening population[J].J Med Virol,2020,92(2):234-240. 10 Xu HF,Zhao XL,Zhao S,et al.Clinical performance of a newly developed domestic urine-based HPV test for cervical cancer screening in China[J].J Med Virol,2023,95(4):e28705. 11 Cho HW,Shim SR,Lee JK,et al.Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer:a systematic review and meta-analysis[J].J Gynecol Oncol,2022,33(1):e4. 12 Kaoma M,Olayemi O,Mwaba MH,et al.Utilizing first void urine for high-risk HPV testing for cervical cancer screening in HIV-positive women in Katete,Zambia[J].BMC Womens Health,2023,23(1):62. 13 Van Keer S,Tjalma WA,Pattyn J,et al.Human papillomavirus genotype and viral load agreement between paired first-void urine and clinician-collected cervical samples[J].Eur J Clin Microbiol Infect Dis,2018,37(5):859-869. 14 周艳秋,胡启彩,杨智敬,等.深圳女性人乳头瘤病毒自取样宫颈癌筛查认知与影响因素调查[J].中华现代护理杂志,2016(17):2426-2430. 15 赵昀,廖琪,米鑫,等.自取样HPV检测技术在子宫颈癌筛查人群中的接受状况调查[J].中华妇产科杂志,2019(5):312-317. 16 Le D,Coriolan Ciceron A,Jeon MJ,et al.Cervical cancer prevention and high-risk HPV self-sampling awareness and acceptability among women living with HIV:a qualitative investigation from the patients' and providers' perspectives[J].Curr Oncol,2022,29(2):516-533. 17 Vega Crespo B,Neira VA,Ortíz SJ,et al.Evaluation of urine and vaginal self-sampling versus clinician-based sampling for cervical cancer screening:a field comparison of the acceptability of three sampling tests in a rural community of cuenca,ecuador[J].Healthcare(Basel),2022,10(9):1614. 18 Shin HY,Lee B,Hwang SH,et al.Evaluation of satisfaction with three different cervical cancer screening modalities:clinician-collected Pap test vs.HPV test by self-sampling vs.HPV test by urine sampling[J].J Gynecol Oncol,2019,30(5):e76. 19 徐慧芳,乔友林.尿液HPV检测的研究进展[J].中国肿瘤,2019,28(09):705-709. 20 Hoffmann R,Lutz SU.The health knowledge mechanism:evidence on the link between education and health lifestyle in the Philippines[J].Eur J Health Econ,2019,20(1):27-43. 21 Sy AU,Hernandez BY,Tareg A,et al.Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap,Federated States of Micronesia[J].Cancer Epidemiol,2017,50(Pt B):283-288. |